Hospitals

Cleveland Clinic-led consortium, 2 other new ‘centers for accelerated innovations’ split $31.5M from NIH

To spark translational research in heart, lung, blood and sleep-related diseases, the National Institutes of Health is doling out $31.5 million to three multi-institution “centers for accelerated innovations.” Specifically, the grants are meant to speed up the commercialization of inventions that would help diagnose, treat, manage or prevent those diseases. Centers in Ohio, California and […]

By Deanna Pogorelc on September 27, 2013

To spark translational research in heart, lung, blood and sleep-related diseases, the National Institutes of Health is doling out $31.5 million to three multi-institution “centers for accelerated innovations.”

Specifically, the grants are meant to speed up the commercialization of inventions that would help diagnose, treat, manage or prevent those diseases.

Centers in Ohio, California and Boston will each get a piece of the $31.5 million through the NIH’s National Heart, Lung and Blood institute. Each center has also secured non-federal funding that matches or exceeds the amount that it’s getting, according to the NIH.

Here are the three centers:

  • Boston Biomedical Innovation Center: Brigham and Women’s Hospital, Boston Children’s Hospital, Massachusetts General Hospital, and President and Fellows of Harvard College
  • Cleveland Clinic Innovation Accelerator: The Cleveland Clinic Lerner College of Medicine, Case Western Reserve University, Cincinnati Children’s Hospital, The Ohio State University, and University of Cincinnati
  • UC BRAID Center for Accelerated Innovation: University of California at Los Angeles, Davis, Irvine, San Diego and San Francisco

The Cleveland Clinic Innovation Accelerator will receive $10.2 million to help fund feasibility studies, entrepreneurial training and mentorship, and regulatory, legal and business development guidance, the clinic said.

Paul DiCorleto, chairman of the Clinic’s Lerner Research Institute, will lead the initiative. He told the Plain Dealer that many of the projects funded could eventually turn into startup companies. That’s territory the clinic knows well; its venture arm, Cleveland Clinic Innovations, has spun out more than 50 companies over the last 13 years.

[Image credit: FreeDigitalPhotos user artur84]